Echo Therapeutics (ECTE) Stock Price, News & Analysis

Company Overview

Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.28
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ECTE Stock Analysis - Frequently Asked Questions

How have ECTE shares performed this year?

Echo Therapeutics' stock was trading at $0.0002 at the beginning of 2025. Since then, ECTE shares have increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2025 here.

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics, Inc. (OTCMKTS:ECTE) issued its quarterly earnings results on Friday, August, 12th. The medical device company reported ($0.82) earnings per share (EPS) for the quarter.

How do I buy shares of Echo Therapeutics?

Shares of ECTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Echo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Echo Therapeutics investors own include DexCom (DXCM), Rexahn Pharmaceuticals (REXN), Acer Therapeutics (ACER), Athersys (ATHX), Blackstone Strategic Credit 2027 Term Fund (BGB), Biocept (BIOC) and BlackRock Science and Technology Trust (BST).

Company Calendar

• Last Earnings: 8/12/2016
• Today: 4/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ECTE
• Previous Symbol: NASDAQ:ECTE
• CIK: 1031927
• Web: www.echotx.com
• Phone: (732) 201-4194
• Fax: 215-717-4109
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A